PMLive12h
AstraZeneca’s Imfinzi regimen approved by FDA to treat muscle-invasive bladder cancer
AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...
PMLive12h
Novartis’ Pluvicto granted FDA approval for expanded prostate cancer use
Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...
PMLive12h
Pfizer’s RSV vaccine receives EC approval for individuals aged 18 to 59 years
Pfizer’s respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) to prevent ...
PMLive12h
OPEN Health appoints Matt D’Auria as CEO
OPEN Health has announced the appointment of Matt D’Auria as its new chief executive officer (CEO). D’Auria brings more than ...
PMLive12h
Is critical thinking at risk?
While AI tools offer undeniable benefits, they also risk diminishing our engagement in deep, reflective thinking and learning ...